Cronos Group and Ginkgo Bioworks Announce Achievement of Equity Milestone in Partnership to Produce Cultured Cannabinoids
23 août 2021 07h30 HE
|
Cronos Group Inc.
TORONTO and BOSTON, Aug. 23, 2021 (GLOBE NEWSWIRE) -- Cronos Group, Inc. (NASDAQ: CRON) (TSX: CRON) ("Cronos Group"), an innovative global cannabinoid company, and Ginkgo Bioworks (“Ginkgo”), which...
Cronos Group Inc. to Speak at the Canaccord Genuity 41st Annual Growth Conference
09 août 2021 17h00 HE
|
Cronos Group Inc.
TORONTO, Aug. 09, 2021 (GLOBE NEWSWIRE) -- Cronos Group Inc. (NASDAQ: CRON) (TSX: CRON) (“Cronos Group” or the “Company”), an innovative global cannabinoid company, today announced that Mike...
Cronos Group Appoints Bob Madore as Chief Financial Officer
06 août 2021 07h33 HE
|
Cronos Group Inc.
TORONTO, Aug. 06, 2021 (GLOBE NEWSWIRE) -- Cronos Group Inc. (NASDAQ: CRON) (TSX: CRON) (“Cronos Group” or the “Company”), an innovative global cannabinoid company, today announced the appointment...
Cronos Group Reports 2021 Second Quarter Results
06 août 2021 07h30 HE
|
Cronos Group Inc.
Amended agreement with Ginkgo Bioworks to accelerate commercialization of cultured cannabinoids Announced strategic investment in PharmaCann, a leading U.S. cannabis company Spinach™ launched new...
Cronos Group Launches Delicious New Dual-Flavor Cannabis Gummies
29 juil. 2021 07h00 HE
|
Cronos Group Inc.
SOURZ by Spinach™ gummies offer adult consumers a bold and juicy new cannabis edible featuring great tasting dual flavors and dual colors TORONTO, July 29, 2021 (GLOBE NEWSWIRE) -- Cronos Group...
Cronos Group Inc. to Hold 2021 Second Quarter Earnings Conference Call on August 6, 2021
23 juil. 2021 08h00 HE
|
Cronos Group Inc.
TORONTO, July 23, 2021 (GLOBE NEWSWIRE) -- Cronos Group Inc. (NASDAQ: CRON) (TSX: CRON) (“Cronos Group” or the “Company”) will hold its 2021 Second Quarter Earnings Conference Call on Friday, August...
Cronos Group Inc. Announces Results of 2021 Annual Meeting of Shareholders
25 juin 2021 16h05 HE
|
Cronos Group Inc.
TORONTO, June 25, 2021 (GLOBE NEWSWIRE) -- Cronos Group Inc. (NASDAQ: CRON) (TSX: CRON) (“Cronos Group” or the “Company”) announces that at its Annual Meeting of Shareholders held earlier today (the...
Cronos Group Announces Strategic Investment in PharmaCann, a Leading U.S. Cannabis Company
14 juin 2021 07h30 HE
|
Cronos Group Inc.
Investment is Expected to Position Cronos Group to Benefit from Rapid Growth in the U.S. Cannabis Market PharmaCann is Well Positioned in Limited License States Across the Midwest and Northeast ...
Cronos Group and Ginkgo Bioworks Amend Agreement to Accelerate Commercialization of Cultured Cannabinoids and Cronos Group Begins Commercial Production of CBG
04 juin 2021 07h30 HE
|
Cronos Group Inc.
BOSTON and TORONTO, June 04, 2021 (GLOBE NEWSWIRE) -- Cronos Group Inc. (NASDAQ: CRON) (TSX: CRON) (“Cronos Group”), an innovative global cannabinoid company, and Ginkgo Bioworks, Inc. (“Ginkgo”),...
Cronos Group Inc. to Participate in Canaccord Genuity’s 5th Annual Global Cannabis Conference on May 11, 2021
10 mai 2021 13h00 HE
|
Cronos Group Inc.
TORONTO, May 10, 2021 (GLOBE NEWSWIRE) -- Cronos Group Inc. (NASDAQ: CRON) (TSX: CRON) (“Cronos Group” or the “Company”), an innovative global cannabinoid company, today announced that Mike...